JP2024528202A5 - - Google Patents
Info
- Publication number
- JP2024528202A5 JP2024528202A5 JP2024506631A JP2024506631A JP2024528202A5 JP 2024528202 A5 JP2024528202 A5 JP 2024528202A5 JP 2024506631 A JP2024506631 A JP 2024506631A JP 2024506631 A JP2024506631 A JP 2024506631A JP 2024528202 A5 JP2024528202 A5 JP 2024528202A5
- Authority
- JP
- Japan
- Prior art keywords
- target sequence
- cells
- rna guide
- gene
- grna
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163228548P | 2021-08-02 | 2021-08-02 | |
| US63/228,548 | 2021-08-02 | ||
| US202163229484P | 2021-08-04 | 2021-08-04 | |
| US63/229,484 | 2021-08-04 | ||
| US202263341346P | 2022-05-12 | 2022-05-12 | |
| US63/341,346 | 2022-05-12 | ||
| US202263346819P | 2022-05-27 | 2022-05-27 | |
| US63/346,819 | 2022-05-27 | ||
| PCT/US2022/074423 WO2023015182A1 (en) | 2021-08-02 | 2022-08-02 | Compositions and methods for gene modification |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024528202A JP2024528202A (ja) | 2024-07-26 |
| JP2024528202A5 true JP2024528202A5 (cg-RX-API-DMAC7.html) | 2025-08-13 |
Family
ID=83558256
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024506631A Pending JP2024528202A (ja) | 2021-08-02 | 2022-08-02 | 遺伝子修飾のための組成物及び方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20250122534A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4381062A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024528202A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022324093A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3228272A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023015182A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3110837A1 (en) | 2018-08-28 | 2020-03-05 | Vor Biopharma Inc. | Genetically engineered hematopoietic stem cells and uses thereof |
| WO2024073751A1 (en) | 2022-09-29 | 2024-04-04 | Vor Biopharma Inc. | Methods and compositions for gene modification and enrichment |
| WO2025030010A1 (en) | 2023-08-01 | 2025-02-06 | Vor Biopharma Inc. | Compositions comprising genetically engineered hematopoietic stem cells and methods of use thereof |
Family Cites Families (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2728782T3 (es) | 2012-05-25 | 2019-10-28 | Univ California | Métodos y composiciones para la modificación de ADN objetivo dirigida por ARN y para la modulación de la transcripción dirigida por ARN |
| WO2014093694A1 (en) | 2012-12-12 | 2014-06-19 | The Broad Institute, Inc. | Crispr-cas nickase systems, methods and compositions for sequence manipulation in eukaryotes |
| EP3129485B2 (en) | 2014-04-09 | 2022-12-21 | Editas Medicine, Inc. | Crispr/cas-related methods and compositions for treating cystic fibrosis |
| CA2969619A1 (en) | 2014-12-03 | 2016-06-09 | Agilent Technologies, Inc. | Guide rna with chemical modifications |
| CN107787367B (zh) | 2015-04-06 | 2021-10-26 | 里兰斯坦福初级大学理事会 | 用于crispr/cas介导的基因调控的化学修饰的引导rna |
| GB201506509D0 (en) | 2015-04-16 | 2015-06-03 | Univ Wageningen | Nuclease-mediated genome editing |
| US9790490B2 (en) | 2015-06-18 | 2017-10-17 | The Broad Institute Inc. | CRISPR enzymes and systems |
| WO2017035388A2 (en) | 2015-08-25 | 2017-03-02 | Snooz, Llc | Machine and method for acoustic white noise generation |
| IL258491B2 (en) | 2015-10-16 | 2023-09-01 | Univ Columbia | Preparations and methods for inhibiting antigens of a particular lineage |
| WO2017070632A2 (en) | 2015-10-23 | 2017-04-27 | President And Fellows Of Harvard College | Nucleobase editors and uses thereof |
| EP3426784A1 (en) | 2016-03-11 | 2019-01-16 | Wageningen Universiteit | Improved crispr-cpf1 genome editing tool |
| KR20260004568A (ko) | 2016-04-19 | 2026-01-08 | 더 브로드 인스티튜트, 인코퍼레이티드 | 신규한 crispr 효소 및 시스템 |
| EP3448995A1 (en) | 2016-04-25 | 2019-03-06 | Universität Basel | Allele editing and applications thereof |
| US10767175B2 (en) | 2016-06-08 | 2020-09-08 | Agilent Technologies, Inc. | High specificity genome editing using chemically modified guide RNAs |
| US11466291B2 (en) * | 2016-07-06 | 2022-10-11 | Cellectis | Sequential gene editing in primary immune cells |
| US20190365806A1 (en) | 2016-11-02 | 2019-12-05 | Universität Basel | Immunologically discernible cell surface variants for use in cell therapy |
| GB201618507D0 (en) | 2016-11-02 | 2016-12-14 | Stichting Voor De Technische Wetenschappen And Wageningen Univ | Microbial genome editing |
| CA3044101A1 (en) | 2016-11-22 | 2018-05-31 | Integrated Dna Technologies, Inc. | Crispr/cpf1 systems and methods |
| CN110249052B (zh) | 2016-12-30 | 2024-04-12 | 爱迪塔斯医药公司 | 合成的指导分子、组合物和与其相关的方法 |
| CN110914310A (zh) | 2017-03-10 | 2020-03-24 | 哈佛大学的校长及成员们 | 胞嘧啶至鸟嘌呤碱基编辑器 |
| IL306092A (en) | 2017-03-23 | 2023-11-01 | Harvard College | Nucleic base editors that include nucleic acid programmable DNA binding proteins |
| AU2018383712B2 (en) | 2017-12-11 | 2025-09-04 | Editas Medicine, Inc. | Cpf1-related methods and compositions for gene editing |
| US12359223B2 (en) * | 2018-01-30 | 2025-07-15 | Editas Medicine, Inc. | Systems and methods for modulating chromosomal rearrangements |
| CN111699254A (zh) * | 2018-02-08 | 2020-09-22 | 齐默尔根公司 | 使用crispr在棒状杆菌属中进行基因组编辑 |
| US20210017277A1 (en) | 2018-03-14 | 2021-01-21 | The United States Of America,As Represented By The Secretary,Department Of Health And Human Services | Anti-cd33 chimeric antigen receptors and their uses |
| CA3110837A1 (en) * | 2018-08-28 | 2020-03-05 | Vor Biopharma Inc. | Genetically engineered hematopoietic stem cells and uses thereof |
| US20200216825A1 (en) | 2019-01-08 | 2020-07-09 | Integrated Dna Technologies, Inc. | CAS12a MUTANT GENES AND POLYPEPTIDES ENCODED BY SAME |
| JP7784707B2 (ja) | 2019-01-16 | 2025-12-12 | ザ・トラスティーズ・オブ・コロンビア・ユニバーシティ・イン・ザ・シティ・オブ・ニューヨーク | 系統特異的抗原の阻害のための組成物および方法 |
| CN113811608B (zh) | 2019-02-22 | 2024-10-29 | 合成Dna技术公司 | 毛螺菌科细菌nd2006 cas12a突变型基因和由其编码的多肽 |
| AU2020280103A1 (en) | 2019-05-23 | 2021-12-23 | Vor Biopharma Inc. | Compositions and methods for CD33 modification |
| WO2021041977A1 (en) | 2019-08-28 | 2021-03-04 | Vor Biopharma, Inc. | Compositions and methods for cd123 modification |
| AU2020338011A1 (en) | 2019-08-28 | 2022-03-10 | Vor Biopharma Inc. | Compositions and methods for CLL1 modification |
| KR20230017783A (ko) * | 2020-04-28 | 2023-02-06 | 인텔리아 테라퓨틱스, 인크. | 시험관내 세포 전달 방법 |
-
2022
- 2022-08-02 EP EP22783650.9A patent/EP4381062A1/en active Pending
- 2022-08-02 US US18/293,882 patent/US20250122534A1/en active Pending
- 2022-08-02 JP JP2024506631A patent/JP2024528202A/ja active Pending
- 2022-08-02 WO PCT/US2022/074423 patent/WO2023015182A1/en not_active Ceased
- 2022-08-02 CA CA3228272A patent/CA3228272A1/en active Pending
- 2022-08-02 AU AU2022324093A patent/AU2022324093A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12214022B2 (en) | Sequence-specific antimicrobials by blocking DNA repair | |
| Enyeart et al. | Generalized bacterial genome editing using mobile group II introns and Cre-lox | |
| AU2025203777A9 (en) | CRISPR-Cas component systems, methods and compositions for sequence manipulation | |
| JP2023541457A5 (cg-RX-API-DMAC7.html) | ||
| CN114075559B (zh) | 一种2型CRISPR/Cas9基因编辑系统及其应用 | |
| AU2016244241A1 (en) | Engineering of systems, methods and optimized guide compositions for sequence manipulation | |
| AU2018341985A1 (en) | CRISPR/Cas system and method for genome editing and modulating transcription | |
| RS60492B1 (sr) | Multipleksirani genomski inženjering omogućen pomoću crispr | |
| JP2022534813A5 (cg-RX-API-DMAC7.html) | ||
| US20240132873A1 (en) | Site-specific genome modification technology | |
| Chandran et al. | TREC-IN: gene knock-in genetic tool for genomes cloned in yeast | |
| Erdmann et al. | SMV1 virus-induced CRISPR spacer acquisition from the conjugative plasmid pMGB1 in Sulfolobus solfataricus P2 | |
| JP2023541458A5 (cg-RX-API-DMAC7.html) | ||
| George et al. | Repair of double-strand breaks in bacteriophage T4 by a mechanism that involves extensive DNA replication | |
| JP2026035762A5 (cg-RX-API-DMAC7.html) | ||
| Takahashi et al. | Genetic recombination through double-strand break repair: shift from two-progeny mode to one-progeny mode by heterologous inserts | |
| EauClaire et al. | A CRISPR/Cas9 method to generate heterozygous alleles in Saccharomyces cerevisiae | |
| JP2023121643A (ja) | II型CRISPR/Cas9遺伝子編集システムとその応用 | |
| JP2023550355A5 (cg-RX-API-DMAC7.html) | ||
| Haider et al. | Fully Transient CRISPR/Cas12f system in plants capable of broad-spectrum resistance against Begomovirus | |
| Palanivelu | Assessment and Analyses of Homing Endonucleases and Mechanism of Action of CRISPR-Cas9 HNH Endonucleases | |
| JP2023538537A (ja) | 核酸の標的化除去のための方法 | |
| Petsche | Construction of a target-specific CRISPR-Cas9 vector for the purpose of introducing mutations into the FUM1 gene of Fusarium verticillioides | |
| JPS6054683A (ja) | 新規dνa及びハイブリツドdνa | |
| CN101311185A (zh) | 一种基于半推理设计的基因体外定向进化体系 |